Phase 3 Nasopharyngeal Carcinoma Clinical Trials
50 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–20 of 50 trials
Recruiting
Phase 3
RAIRI Model-Guided Adjuvant Therapy in Nasopharyngeal Carcinoma
Nasopharyngeal Carcinoma (NPC)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences651 enrolled1 locationNCT07590024
Recruiting
Phase 3
Maintenance Therapy With Toripalimab and Capecitabine Versus Capecitabine Alone in High-risk Nasopharyngeal Carcinoma
Nasopharyngeal CarcinomaHigh-Risk CancerMaintenance Therapy
Jiangxi Provincial Cancer Hospital264 enrolled3 locationsNCT06277050
Recruiting
Phase 3
Effect of Standard Nutrition Therapy on Nutritional Status and Prognosis in Locoregionally Advanced Nasopharyngeal Carcinoma Patients With Malnutrition
Nasopharyngeal CarcinomaNutrition Therapy
Sun Yat-sen University266 enrolled1 locationNCT04436965
Recruiting
Phase 3
IC Plus Low-dose Radiation Plus Cadonilimab in LANPC
ChemotherapyRadiotherapyImmune Checkpoint Inhibitor+1 more
Sun Yat-sen University380 enrolled3 locationsNCT05941741
Recruiting
Phase 3
Chemoradiotherapy Plus Anti-PD1 in Recurrent NPC: A Multicenter, Open-label, Randomised, Controlled, Phase III Trial
Nasopharyngeal Carcinoma
Sun Yat-sen University212 enrolled12 locationsNCT05340491
Recruiting
Phase 3
PD-1 Antibody Combined With Chemoradiotherapy in Recurrent Nasopharyngeal Carcinoma Patients
Recurrent Nasopharyngeal Carcinoma
Sun Yat-sen University212 enrolled12 locationsNCT03907826
Recruiting
Phase 3
Camrelizumab Plus Stereotactic Body Radiotherapy vs Camrelizumab Alone For Oligometastatic Nasopharyngeal Carcinoma
Nasopharyngeal Carcinoma
Sun Yat-sen University188 enrolled1 locationNCT04944914
Recruiting
Phase 3
Becotatug Vedotin Plus Sintilimab in Locoregionally Advanced NPC
Nasopharyngeal Carcinoma (NPC)
First Affiliated Hospital of Guangxi Medical University266 enrolled1 locationNCT07459296
Recruiting
Phase 3
Reduced-dose Radiotherapy for Stage III Nasopharyngeal Carcinoma Based on the Treatment Response
Nasopharyngeal Carcinoma
Sun Yat-sen University593 enrolled26 locationsNCT06239727
Recruiting
Phase 3
Sapylin Versus Dexamethasone Inhalation for CCRT-Induced Oral Mucositis in Nasopharyngeal Carcinoma
Nasopharyngeal Carcinoma (NPC)
Affiliated Hospital of Guangdong Medical University180 enrolled1 locationNCT07327216
Recruiting
Phase 3
A Study of MRG003 in Combination With Pucotenlimab Versus Chemotherapy in the Treatment of Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma
Recurrent or Metastatic Nasopharyngeal Carcinoma
Shanghai Miracogen Inc.446 enrolled1 locationNCT06976190
Recruiting
Phase 3
Proton vs Photon IMRT in Locally Advanced Nasopharyngeal Carcinoma: A Phase III Trial
Nasopharyngeal Carcinoma (NPC)
Man Hu300 enrolled1 locationNCT07340515
Recruiting
Phase 3
Reduced-dose Versus Conventional-dose Intensity-modulated Radiation Therapy for Locally Advanced Nasopharyngeal Carcinoma With Remission After Induction Chemotherapy and Immunotherapy
Nasopharyngeal Carcinoma (NPC)
Ming-Yuan Chen456 enrolled12 locationsNCT07328841
Recruiting
Phase 3
40.2Gy Versus 49.2Gy Radiotherapy in Low-Risk Target Volume for Chemosensitive Stage II Nasopharyngeal Carcinoma
Nasopharyngeal Carcinoma
Ming-Yuan Chen346 enrolled15 locationsNCT07328854
Recruiting
Phase 3
Individualized Neck Cervical Irradiation Prophylaxis Trial of NPC
Nasopharyngeal Carcinoma (NPC)
Fudan University462 enrolled6 locationsNCT07303023
Recruiting
Phase 3
Phase III Non-Inferiority Trial: Reduced-Target vs. Full-Target IMRT After Chemo in Immunotherapy-Treated Metastatic Nasopharyngeal Cancer
Nasopharyngeal Carcinoma (NPC)
Ming-Yuan Chen166 enrolled1 locationNCT07188584
Recruiting
Phase 3
Individualized Elective Neck Irradiation in NPC Patients
Nasopharyngeal Carcinoma
Sun Yat-sen University470 enrolled1 locationNCT06241612
Recruiting
Phase 3
Tislelizumab Plus GX Versus Tislelizumab Plus GP in the Treatment of R/M NPC
Nasopharyngeal Carcinoma
Fudan University266 enrolled1 locationNCT06177301
Recruiting
Phase 3
Adjuvant vs Surgery Only in Early-stage Recurrent NPC
Recurrent Nasopharyngeal Carcinoma
Eye & ENT Hospital of Fudan University176 enrolled7 locationsNCT06228079
Recruiting
Phase 3
Neoadjuvant vs Adjuvant in Locally Advanced Recurrent NPC
Recurrent Nasopharyngeal Carcinoma
Eye & ENT Hospital of Fudan University154 enrolled7 locationsNCT06235203